CPhI Announces US-Market Report at InformEx - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Announces US-Market Report at InformEx


CPhI Worldwide announced the launch of the CPhI Pharma InsightsUSA market report, a joint venture with InformEx, which will provide European perspectives on the accessibility, growth, and export market in the United States. The report is designed to encourage and increase trade harmonization between the two major pharma economies of the world, the sponsors say.

The US country report, which will be distributed in July 2014, follows the launch of the CPhI annual report (released at CPhI Worldwide, Frankfurt, October 2013). The new report, which analyzes current and future trends across the US pharma landscape, will feature expert opinion from Europe’s leading companies, contrasted with US internal perceptions to provide a holistic view of the major trade flows within the region, according to report sponsors.

The report will examine the areas in which European companies are looking to work with US counterparts, import into the US and, domestic and export manufacturing across pharma’s fine, specialty, and custom chemicals market.

Following last year’s report, which covered the global industry, CPhI will now examine trends within specific leading pharma economies.

Source: CPhI

 

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges

Click here